Shanghai Changde Medical Technology
Health Tech & Medtech · China · Founded 2021
Comprehensive solutions for vascular diseases using minimally invasive techniques and advanced medical devices MoreLess
Easy Flow Medtech is dedicated to developing comprehensive solutions for the treatment of vascular diseases through minimally invasive techniques. The company focuses on creating a range of medical devices, including balloons, stents, thrombus aspiration equipment, and catheters, aimed at treating conditions such as peripheral arterial stenosis, vascular thrombus, and varicose veins. Easy Flow Medtech operates in the medical device market, serving healthcare providers and patients who require advanced treatment options for vascular conditions. The business model revolves around independent research and development, as well as collaborations with domestic and international partners to accelerate product development. Revenue is generated through the sale of these specialized medical devices. The Mechanical Pulse Pressure Pump, a key product, is designed to enhance arm vessel circulation and expedite the maturation of arteriovenous fistulas (AVFs). Additionally, the company is conducting a multi-center, randomized controlled trial to evaluate the safety and efficacy of its peripheral drug-eluting stent, which offers prolonged drug release and therapeutic effects, particularly for patients with complex vascular lesions. Keywords: vascular diseases, minimally invasive, medical devices, balloons, stents, thrombus aspiration, catheters, peripheral arterial stenosis, drug-eluting stent, arteriovenous fistulas.
Company overview
Shanghai Changde Medical Technology company information
The essential company record, classifications and operating signals in one place.
- Status
- Operational
- Founded
- 2021
- Headquarters
- China
- Employees
- —
- Open positions
- None listed
- Dealroom signal
- 19.0
Valuation & funding
Shanghai Changde Medical Technology funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | Apr 2025 | $14M | $55M | Legend Capital · Industrial Securities Capital · Shanghai Biomedicine Fund | ↗ |
Growth signals
Shanghai Changde Medical Technology website traffic
Latest recorded traffic for Shanghai Changde Medical Technology is 1.4K monthly website visits, up 1172.7% over the last three months.
Comparisons
Shanghai Changde Medical Technology compared with similar companies
Dealroom’s weighted taxonomy model identifies the closest operating peers. Company identity and context stay open; selected comparison metrics preview what is available in the platform.
| Company | Headquarters | Status | Employees | Total funding | Valuation |
|---|---|---|---|---|---|
ValCare MedicalMedical device company, designs and develops devices and accessories for minimally invasive treatment of heart valve |
Herzliya, Israel | Operational | 38 | $8M | — |
| Osaka, Japan | Operational | ||||
PolyemboVessel embolization device for peripheral vascular procedures |
Longmont, United States | Operational | |||
Apreo HealthAirway scaffold implant for severe emphysema treatment |
Stockholm, United States | Operational | |||
Versa VascularMinimally invasive implant for tricuspid valve regurgitation |
United States | Operational | |||
VahatiCor IncCoronary sinus reducer for microvascular dysfunction treatment |
Santa Clara, United States | Operational | |||
Archo MedicalEndovascular devices for complex aortic aneurysm treatment |
Biguaçu, Brazil | Operational | |||
Inquis MedicalA privately clinical stage medical device company based in Silicon Valley |
Menlo Park, United States | Operational |
Talent graph
Shanghai Changde Medical Technology's talent
Source: Dealroom Talent Intelligence.
Global footprint
Where Shanghai Changde Medical Technology has talent and traffic
In the news
Latest news about Shanghai Changde Medical Technology
Recent press, funding announcements, and product moves mentioning Shanghai Changde Medical Technology — open to read from the original sources.
Market sentiment
What the market is saying about Shanghai Changde Medical Technology
An AI-synthesized read of the highest-engagement posts about Shanghai Changde Medical Technology on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Shanghai Changde Medical Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.








